MiNK Therapeutics, Inc. (INKT) stock
INKTNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$9.29−0.06 (-0.70%)
Close on Nov 17, 2026Market cap $47.38MP/E –Yield –
MiNK Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
MiNK Therapeutics's price to book ratio was 11.2× on Jan 31, 2023.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2023 | Jan 31, 2023 | 11.2× | −1.6 |
| 2022 | Dec 30, 2022 | 12.8× | – |
See a number that looks wrong?